https://vitalspanwire.com/news/fda-rusfertide-polycythemia-vera-approvalVitalspan Wireen2026-09-01T21:02:03.114ZFDA approves hepcidin-mimicking peptide rusfertide for polycythemia verahttps://vitalspanwire.com/news/sprintt-multimorbidity-mobility-disability-analysisVitalspan Wireen2026-09-01T16:01:41.047ZSPRINTT analysis finds mobility benefit, but disease-pattern differences remain uncertainhttps://vitalspanwire.com/news/dog-aging-project-multimorbidity-mortalityVitalspan Wireen2026-09-01T11:01:58.960ZDog Aging Project links multiple chronic conditions to higher mortalityhttps://vitalspanwire.com/news/nitric-oxide-switch-inflammation-responsive-proteinsVitalspan Wireen2026-08-31T21:04:10.190ZNitric-Oxide Switch Reactivates Engineered Proteins in Inflamed Mouse Tissuehttps://vitalspanwire.com/news/oral-anticoagulants-valve-clots-tavi-acasa-trialVitalspan Wireen2026-08-31T16:03:57.030ZOral anticoagulants reduced CT-detected valve clots after TAVI in randomized trialhttps://vitalspanwire.com/news/oocyte-mitochondrial-dna-leakage-ovarian-agingVitalspan Wireen2026-08-31T11:04:08.963ZMouse study traces ovarian aging to mitochondrial DNA leakage in oocytes